Sector
PharmaceuticalsOpen
₹2,024Prev. Close
₹1,918.55Turnover(Lac.)
₹97.92Day's High
₹2,024Day's Low
₹1,85052 Week's High
₹2,34852 Week's Low
₹773.28Book Value
₹0Face Value
₹10Mkt Cap (₹ Cr.)
1,131.26P/E
67.2EPS
28.55Divi. Yield
0.131 Aug 2023
12:00 AM
BookCloser
31 Aug 2023
12:00 AM
AGM
Announcement Date: 31 Aug, 2023
23 Apr 2024
12:00 AM
EGM
23 Apr 2024
12:00 AM
Dividend
Dividend Amount: 4
Record Date: 02 May, 2024
10 Jun 2024
12:00 AM
Board Meeting
Agenda : Audited Result
4 Jun 2024
12:00 AM
Bonus
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 1.09 | 1 | 0.01 | 0.01 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 18.05 | 5.58 | 3.13 | 2.01 |
Net Worth | 19.14 | 6.58 | 3.14 | 2.02 |
Minority Interest |
No Record found
No Record found
No Record found
| Particulars (Rupees in Crores.) | Mar-2024 |
|---|---|
Gross Sales | 212.5 |
Excise Duty | 0 |
Net Sales | 212.5 |
Other Operating Income | 0 |
Other Income | 5.4 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,568.65 | 123.31 | 3,76,323.69 | 867.6 | 0.86 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,519.8 | 76.17 | 1,19,994.45 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,485.5 | 32.29 | 1,19,928.54 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,144.45 | 33.51 | 1,15,173.54 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,636 | 25.85 | 1,10,759.07 | 1,034.8 | 0.6 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
No Record Found
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Remus Pharmaceuticals Ltd
Summary
Remus Pharmaceuticals Limited was originally incorporated as Remus Pharmaceuticals Private Limited as a private limited company, vide Certificate of Incorporation dated September 21, 2015, issued by the Assistant Registrar of Companies, Gujarat. Subsequently, Company converted from a private company to public company and consequently, the name of Company was changed to Remus Pharmaceuticals Limited on January 06, 2023 by the Registrar of Companies, Ahmedabad.The Company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs. It deals in API (Active Pharmaceutical Ingredient), provide technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries. The Company deal in drug forms like Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nail Lacquer, Nasal Solution, Nasal Spray, Nebuliser, Ointment, Ophthalmic, Oral Gel, Oral Solution, Oral Suspension, Sachet, Suspension, Tablet. The core business of the Company into three categories, which comprise of Manufacturing, through loan licencse or on contract manufacturing bassis, of approved finished formulations and distribution of the same in various countries; Trading of Active Pharmaceutical Ingredients and Technical Consultancy on preparation of reports on pharmaceutical dossiers.The product portfolio comprises of therapeutic drugs like ACE inhibitors, anaesthetic, Anti histamin
Read More
What is the Remus Pharmaceuticals Ltd share price today?
The Remus Pharmaceuticals Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is Rs.₹1920 today.
What is the Market Cap of Remus Pharmaceuticals Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Remus Pharmaceuticals Ltd is ₹1131.26 Cr. as of 22 Jul ‘24
What is the PE and PB ratio of Remus Pharmaceuticals Ltd?
The PE and PB ratios of Remus Pharmaceuticals Ltd is 67.2 and 13.77 as of 22 Jul ‘24
What is the 52 Week High and Low of Remus Pharmaceuticals Ltd?
The 52-week high/low is the highest and lowest price at which a Remus Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Remus Pharmaceuticals Ltd is ₹773.28 and ₹2348 as of 22 Jul ‘24
What is the CAGR of Remus Pharmaceuticals Ltd?
Remus Pharmaceuticals Ltd's CAGR for 5 Years at N/I%, 3 Years at N/I%, 1 Year at 129.28%, 6 Month at 21.52%, 3 Month at 24.10% and 1 Month at -7.53%.
What is the shareholding pattern of Remus Pharmaceuticals Ltd?
The shareholding pattern of Remus Pharmaceuticals Ltd is as follows:
Promoters - 70.66 %
Institutions - 3.72 %
Public - 25.61 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
